CVRx, Inc. (CVRX)
Nasdaq: CVRX · Surgical & Medical Instruments & Apparatus · Minneapolis, MN · filing with the SEC since 2003
Who owns CVRx, Inc.
As filed with the SECHolders of 5% or more
3
Johnson & Johnson holds 15.4% of Common Stock, $0.01 par value, as its SCHEDULE 13G/A filed Jan 12, 2026 says.
Directors and officers
15
report now, of 23 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 3 named at left.
Holders of 5% or moreshare of the class, as filed
Johnson & Johnson
SCHEDULE 13G/A · filed Jan 12, 2026 · Common Stock, $0.01 par value
New Enterprise Associates 10, Limited Partnership
SCHEDULE 13D/A · filed Feb 20, 2025 · Common Stock, par value $0.01 per share
Kirk Nielsen
SCHEDULE 13G/A · filed Feb 6, 2025 · Common Stock, $0.01 par value per share
Cooperatieve Gilde Healthcare IV U.A.
SCHEDULE 13D/A · filed Feb 6, 2025 · Common Stock, $0.01 par value per share · reported falling below 5%
Chernett Jorey
SCHEDULE 13D/A · filed Oct 2, 2026 · Common Stock, $0.01 par value · reported falling below 5%, from 5.5% in Aug 24, 2026
What CVRX reports owning in othersstakes of 5% or more, and other ties
CVRx, Inc. reports no stake in another company in the record.
Insider tradesForm 4
6sales
3purchases
6sales on a scheduled plan
6people selling
$100,000sold, in dollars
$400,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window9 of 29 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Johnson & Johnson Innovation - Jjdc, Inc. | 10% owner | 2 | $200,000 | 0 | 0 | $0 |
| Hykes Kevin | PRES & CEO | 1 | $100,000 | 1 | 0 | $0 |
| Johnson & Johnson | 10% owner | 4 | $100,000 | 0 | 0 | $0 |
| Jain Mudit K. | director | 0 | $0 | 0 | 2 | $300,000 |
| Binkowski Brent | CHIEF OPERATING OFFICER | 1 | $0 | 1 | 1 | $100,000 |
| Oasheim Jared | CHIEF FINANCIAL OFFICER | 1 | $0 | 1 | 0 | $0 |
| Adamson Philip B. | Chief Medical Officer | 1 | $0 | 1 | 0 | $0 |
| John Robert Allen | Chief Revenue Officer | 1 | $0 | 1 | 0 | $0 |
| Verrastro Paul | CHIEF MKTG & STRAT OFFICER | 1 | $0 | 1 | 0 | $0 |